Today we'll look at Psychemedics Corporation (NASDAQ:PMD) and reflect on its potential as an investment. In...
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...
ACTON, Mass., Oct. 22, 2019 -- Psychemedics Corporation (NASDAQ:PMD) today announced third quarter financial results for the period ended September 30, 2019. The Company also.
If you own shares in Psychemedics Corporation (NASDAQ:PMD) then it's worth thinking about how it contributes to the...
Psychemedics Corporation (PMD) today issued a response to a Massachusetts Supreme Judicial Court ruling in the case of Boston Police Department v. The Massachusetts Civil Service Commission, which dealt with the Boston Police Department’s 2012 decision not to hire an applicant after the applicant failed a Psychemedics Hair Test. Previously, a Massachusetts Superior Court Judge had found that the Boston Police Department’s reliance on the test was proper. The Massachusetts Supreme Judicial Court overturned the Superior Court’s decision, citing as one of its grounds the applicant’s “ardent” denials of drug use during his testimony before the Massachusetts Civil Service Commission (CSC), but also acknowledging that it could not consider “facts and studies” that the Court found were not before the CSC.
Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced a Vaping Panel to detect the use of Marijuana, CBD and Nicotine. This test provides a way for schools and businesses to detect the ingestion of these drugs by all methods including electronic cigarettes or smoking. Hair testing provides several significant advantages over other methods of testing including a 90-day lookback period for the ingestion of drugs.
ACTON, Mass., Feb. 11, 2020 -- Psychemedics Corporation (NASDAQ:PMD) today announced fourth quarter and year-end financial results for the period ended December 31, 2019. The.
Psychemedics Corporation (PMD) will hold its Annual Meeting of Stockholders (“Annual Meeting”) on Thursday, May 14, 2020 at 2:00 p.m. ET. Psychemedics Corporation has decided to hold the Annual Meeting in a virtual meeting format for this year, in light of public health concerns regarding the COVID-19 outbreak. As described in the proxy materials for the Annual Meeting, shareholders who held their shares as of the close of business on March 17, 2020, the record date, are entitled to vote in the Annual Meeting.
Amtech Systems tops the list Continue reading...
Today we'll take a closer look at Psychemedics Corporation (NASDAQ:PMD) from a dividend investor's perspective. Owning...
Psychemedics Corporation (PMD) announced today that it has entered into a new distribution agreement in Brazil with Sansão Holding S.A. and with Toxicologia Pardini Ltda., our existing independent distributor in Brazil, formerly known as Psychemedics Brasil Exames Toxicológicos Ltda. The new agreement replaces our prior distribution agreement with Psychemedics Brasil. As we previously disclosed, Psychemedics Brasil had a majority of its shares acquired by Instituto Hermes Pardini S.A. (IHP), a provider of medical and diagnostic services in Brazil, including reference laboratory services.
Psychemedics Corporation (NASDAQ:PMD) shareholders should be happy to see the share price up 20% in the last month...
In 1991, Raymond Kubacki was appointed CEO of Psychemedics Corporation (NASDAQ:PMD). This analysis aims first to...
Unfortunately for some shareholders, the Psychemedics (NASDAQ:PMD) share price has dived 35% in the last thirty days...
Unfortunately for some shareholders, the Psychemedics (NASDAQ:PMD) share price has dived 32% in the last thirty days...
ACTON, Mass., May 13, 2020 -- Psychemedics Corporation (NASDAQ:PMD) today announced first quarter financial results for the period ended March 31, 2020. The Company’s revenue.
Today, we'll introduce the concept of the P/E ratio for those who are learning about investing. To keep it practical...
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade. Most investors who decided to stick with hedge funds after a rough 2018 recouped their losses by the end of the third quarter. We get to see hedge funds' thoughts towards the market and […]
Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced the first FDA-cleared hair test for cotinine, the predominant metabolite for nicotine. This test provides a way for schools and businesses to detect the ingestion of nicotine by all methods including smoking or the use of electronic cigarettes. Hair testing provides several significant advantages over other methods of testing including a 90-day lookback period for the ingestion of drugs.